Galderma expands Alastin regenerative skincare across Japan and Asia Pacific

Galderma is expanding its Alastin Skincare brand across the Japan and Asia Pacific region, a move that signals a tightening global standard for integrated peri-procedural care. For clinics operating internationally or managing patients who travel, this rollout establishes a consistent post-treatment protocol across markets. The expansion introduces nine core products to the region, including Regenerating Skin Nectar, INhance Post-Injection Serum, and the Restorative Skin Complex with TriHex+ technology. These formulations rely on proprietary peptides designed to clear damaged collagen and elastin while supporting new structural protein synthesis. Backed by more than 60 international dermatological publications and over 25 granted patents, the line is positioned heavily around clinical validation. Following launches in Taiwan, China, and Australia, Galderma plans to introduce the brand to Singapore in September 2026, followed by South Korea in November 2026, alongside an upcoming launch in Japan. If you run an international practice or cater to medical tourists in these regions, this expansion allows you to prescribe the same pre- and post-procedure regimens patients use at home, maintaining treatment continuity and protecting your clinical outcomes.

Source: Business Wire, https://www.businesswire.com/news/home/20260719444150/en